Abstract

Metabolism is deeply involved in cell behavior and homeostasis maintenance, with metabolites acting as molecular intermediates to modulate cellular functions. In particular, one-carbon metabolism is a key biochemical pathway necessary to provide carbon units required for critical processes, including nucleotide biosynthesis, epigenetic methylation, and cell redox-status regulation. It is, therefore, not surprising that alterations in this pathway may acquire fundamental importance in cancer onset and progression. Two of the major actors in one-carbon metabolism, folate and choline, play a key role in the pathobiology of epithelial ovarian cancer (EOC), the deadliest gynecological malignancy. EOC is characterized by a cholinic phenotype sustained via increased activity of choline kinase alpha, and via membrane overexpression of the alpha isoform of the folate receptor (FRα), both of which are known to contribute to generating regulatory signals that support EOC cell aggressiveness and proliferation. Here, we describe in detail the main biological processes associated with one-carbon metabolism, and the current knowledge about its role in EOC. Moreover, since the cholinic phenotype and FRα overexpression are unique properties of tumor cells, but not of normal cells, they can be considered attractive targets for the development of therapeutic approaches.

Highlights

  • Cancer is a disease of uncontrolled growth, in which cells undergo genetic and epigenetic changes that affect critical cellular functions

  • One-carbon metabolism is a key biochemical pathway necessary to provide carbon units required for critical processes, including nucleotide biosynthesis, epigenetic methylation, and cell redox-status regulation

  • epithelial ovarian cancer (EOC) is characterized by a cholinic phenotype sustained via increased activity of choline kinase alpha, and via membrane overexpression of the alpha isoform of the folate receptor (FRα), both of which are known to contribute to generating regulatory signals that support EOC cell aggressiveness and proliferation

Read more

Summary

Introduction

Cancer is a disease of uncontrolled growth, in which cells undergo genetic and epigenetic changes that affect critical cellular functions. Accumulating evidence suggests that oncogenic signaling is linked to multiple metabolic rearrangements that confer selective advantages to cancer cells, allowing them to proliferate outside the context of normal tissue development and to meet the requirements for sustaining a transformed cellular steady state. Metabolic reprogramming and metabolites themselves can interfere with oncogenic-driven cell signaling and cancer transformation. These alterations can be evaluated as likely therapeutic targets to develop novel approaches to improve the efficacy of standard chemotherapeutic treatments [6,7]. In this review we highlight the metabolism and metabolites involved in the one-carbon cycle in epithelial ovarian cancer (EOC), identify possible therapeutic applications

Pathobiology
Metabolic Alterations
One-Carbon Metabolism in Physiology and Cancer
Trans-Sulfuration and GSH
DNA Biosynthesis
One-Carbon-Metabolism-Dependent Processes and EOC
Folate Metabolism
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call